Plasma DNA, Microsatellite Alterations, and p53 Tumor Mutations Are Associated with Disease-Free Survival in Radically Resected Non-small Cell Lung Cancer Patients: A Study of the Perugia Multidisciplinary Team for Thoracic Oncology

Vienna Ludovini, Lorenza Pistola, Vanesa Gregorc, +14

Journal of Thoracic Oncology

Plasma DnaPerugia Multidisciplinary TeamMedicinePathologyCancer Genomics +6

Short-Course Palliative Radiotherapy in Non–Small-Cell Lung Cancer

Marco Lupattelli, Ernesto Maranzano, Rita Bellavita, +4

American Journal of Clinical Oncology

A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group

Lucio Crinò, Maurizio Tonato, Samir Darwish, +9

Cancer Chemotherapy and Pharmacology

Cisplatin-containing RegimensMedicineBronchial NeoplasmRandomized TrialCancer Treatment +5

Biological prognostic factors for early stage completely resected non-small cell lung cancer

Lucio Cagini, Massimo Monacelli, Giammario Giustozzi, +9

Journal of Surgical Oncology

Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer

Vienna Ludovini, Vanesa Gregorc, Lorenza Pistola, +10

Lung Cancer

OncologyMedicineImmunologyPathologyBronchial Neoplasm +7

Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer

Vanesa Gregorc, Vienna Ludovini, Lorenza Pistola, +9

Lung Cancer

Cisplatin-based ChemotherapyMedicineBronchial NeoplasmAnti-cancer AgentCell Biology +7

Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA‐bulky N2 and Stage IIIB nonsmall cell lung carcinoma

Federico Cappuzzo, Giovanni Selvaggi, Vanesa Gregorc, +13

Cancer

A Prospective Analysis of Chemotherapy Following Surgical Resection of Clinical Stage I-II Small-Cell Lung Cancer

Stephen Davis, Lucio Crinò, Maurizio Tonato, +3

American Journal of Clinical Oncology

Consecutive PatientsSurgical OncologyRadiation TherapyMedian SurvivalMedicine +11

Induction therapy for NSCLC: a consensus report

Jean Klášterský, Ronald L. Burkes, Noah C. Choi, +15

Lung Cancer

Clinical TrialsConsensus ReportPharmacotherapyMedicineNovel Therapy +1

Neoadjuvant Cisplatin and Etoposide for Stage IIIA (Clinical N2) Non-Small Cell Lung Cancer

Samir Darwish, V. Minotti, Lucio Crinò, +10

American Journal of Clinical Oncology